Alex Denner secures victory in Amarin vote, ousting chair and adding supporters to board
Just weeks after activist investor Alex Denner called for Amarin’s chairman to step down, the Irish biotech’s shareholders have voted in Denner’s favor.
Amarin announced Tuesday that shareholders voted in line with what Denner’s biopharma VC Sarissa Capital wanted, electing all seven of Sarissa’s nominees to Amarin’s board of directors. Chairman Per Wold-Olsen was also voted out, effective immediately.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.